SPDR S&P Pharmaceuticals ETF $XPH Stake Boosted by Goldman Sachs Group Inc.

Goldman Sachs Group Inc. increased its stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 96.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 119,929 shares of the company’s stock after purchasing an additional 59,007 shares during the quarter. Goldman Sachs Group Inc. owned approximately 3.29% of SPDR S&P Pharmaceuticals ETF worth $5,253,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Simplex Trading LLC acquired a new stake in SPDR S&P Pharmaceuticals ETF during the 1st quarter worth about $27,000. Blair William & Co. IL acquired a new stake in SPDR S&P Pharmaceuticals ETF during the 1st quarter worth about $30,000. NBC Securities Inc. boosted its position in SPDR S&P Pharmaceuticals ETF by 107,050.0% during the 1st quarter. NBC Securities Inc. now owns 2,143 shares of the company’s stock worth $93,000 after acquiring an additional 2,141 shares during the period. Captrust Financial Advisors boosted its position in SPDR S&P Pharmaceuticals ETF by 9.4% during the 4th quarter. Captrust Financial Advisors now owns 5,827 shares of the company’s stock worth $251,000 after acquiring an additional 500 shares during the period. Finally, Sigma Planning Corp boosted its position in SPDR S&P Pharmaceuticals ETF by 14.5% during the 1st quarter. Sigma Planning Corp now owns 5,894 shares of the company’s stock worth $258,000 after acquiring an additional 747 shares during the period.

SPDR S&P Pharmaceuticals ETF Trading Down 0.0%

Shares of NYSEARCA XPH opened at $45.99 on Wednesday. SPDR S&P Pharmaceuticals ETF has a one year low of $35.22 and a one year high of $48.76. The firm has a market capitalization of $165.56 million, a PE ratio of 14.28 and a beta of 0.84. The business has a 50-day moving average price of $44.72 and a two-hundred day moving average price of $42.25.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.